TOP TIERMARKET NEWSWIRE
News & sentiment

PROTAGONIST THERAPEU (PTGX) — News & AI sentiment

PROTAGONIST THERAPEU (PTGX) news roundup. 5 stories in the past week, 23 over 30 days. Average 30-day sentiment is 64.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $34.2M — net selling of $34.2M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 1 sale (~$33K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 68.4/100
30d stories
23
avg sentiment 64.5/100
Insider net (90d)
$34.2M
0 buys · 3 sells
Congress (90d)
-1
0 buys · 1 sells

PTGX news in the last 24 hours, 7 days, 30 days and 90 days

How much PTGX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPTGX storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days568.4/100PTGX headlines →
Last 30 days2364.5/100PTGX headlines →
Last 90 days4160.8/100PTGX headlines →

Latest stories on PTGX

4d ago
5d ago
5d ago
5d ago
7d ago
Sep 4
Sep 2
BMO raises Protagonist Therapeutics price target on Mimrylo approval
Investing.com Analyst Ratings61 · neutralanalyst
Sep 1
H.C. Wainwright raises Protagonist stock price target on FDA approval
Investing.com Analyst Ratings67 · bullishanalyst
Sep 1
Sep 1
Sep 1
Aug 31
Aug 31
Protagonist Therapeutics stock rating maintained at Buy by Clear Street
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Aug 31
Aug 31
Aug 31
Aug 31
Aug 30
Aug 29
Aug 28
Aug 18
Aug 17
Aug 12
Aug 10
Open PTGX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →